MTOR and hepatocellular carcinoma: Mechanistically, we further demonstrated that celecoxib abrogated the activation of Akt/mTOR signalling in insulin‐stimulated hepatoma cells, followed by the reduction of downstream lipogenic proteins at the post‐transcriptional level in chronically insulin‐treated cohorts.